Pemrest 100 mg (Pembrolizumab) Injection
Introduction Pemrest 100 mg (Pembrolizumab) is a groundbreaking, highly advanced oncology medication classified as a humanized monoclonal antibody and immune checkpoint inhibitor. Manufactured under strict quality controls by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Pemrest represents a paradigm shift in precision cancer care. Rather than directly targeting tumor cells, this immunotherapy unmasks […]
Enzamide 40 mg (Enzalutamide) Tablets
Introduction Enzamide 40 mg (Enzalutamide) is a highly potent, targeted oncology medication classified as a second-generation androgen receptor inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Enzamide represents a standard-of-care therapy for advanced prostate cancer. It is specifically designed to treat prostate malignancies that continue to progress despite surgical or medical […]
Encoraf 75 mg (Encorafenib) Tablets
Introduction Encoraf 75 mg (Encorafenib) is a highly potent, targeted oncology medication classified as a small-molecule BRAF kinase inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Encoraf represents a critical milestone in precision medicine. It is specifically designed to target the mutated BRAF V600E protein, which acts as an unregulated accelerator […]
Upajaf 15 mg (Upadacitinib) Tablets
Introduction Upajaf 15 mg (Upadacitinib) is a next-generation, oral, targeted immunomodulatory medication classified as a highly selective Janus kinase (JAK) inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Upajaf represents a breakthrough in the treatment of chronic, progressive autoimmune and inflammatory conditions. By selectively blocking specific intracellular pathways that trigger systemic […]
Abemaxen 150 mg (Abemaciclib INN) Tablets
Introduction Abemaxen 150 mg (Abemaciclib) is a highly potent, targeted oncology medication classified as a CDK4 and CDK6 inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Abemaxen is a cornerstone therapy for advanced breast cancer. It works by blocking specific proteins that allow cancer cells to grow and divide rapidly. Unlike […]
Quizar 17.7 MG (Quizartinib) Tablets
Introduction Quizar 17.7 mg (Quizartinib) is a highly potent, second-generation, selective small-molecule inhibitor of the Fms-like tyrosine kinase 3 (FLT3) receptor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Quizar is an advanced targeted therapy specifically for patients with Acute Myeloid Leukemia (AML). It is primarily used to treat adult patients with […]
Lazerib 80 MG (Lazertinib) Tablets
Introduction Lazerib 80 mg (Lazertinib) is a cutting-edge, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, this medication is a breakthrough for patients with non-small cell lung cancer (NSCLC). Lazerib is specifically designed to target both the common EGFR mutations and the […]
Repotrex 40 MG (Repotrectinib) Capsules
Introduction Repotrex 40 mg (Repotrectinib) is a next-generation, potent tyrosine kinase inhibitor (TKI) designed for precision oncology. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Repotrex is specifically engineered to target ROS1 and NTRK gene fusions. This medication is a life-saving therapy for patients with locally advanced or metastatic non-small cell lung […]
Binixen 15 MG (Binimetinib) Tablets
Introduction Binixen 15 mg (Binimetinib) is a potent, targeted oncology medication categorized as a MEK inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, this drug is a breakthrough in precision medicine. Binixen is specifically designed to treat cancers driven by the BRAF V600 mutation, including advanced melanoma and non-small cell lung […]
Revlixen 10 mg (Lenalidomide) Capsule
Introduction Revlixen 10 mg Capsule contains Lenalidomide, an immunomodulatory drug primarily used in the treatment of various hematological cancers. It is known for its potent anti-cancer, antiangiogenic, and immunomodulatory effects. Revlixen is manufactured by Everest Pharmaceuticals Ltd and is supplied globally by Onco Solution — your trusted oncology medicine partner. Key Benefits Indications Revlixen 10 […]
Liposem 2 MG (Saroglitazar Magnesium) Tablets
Introduction Liposem 2 mg (Saroglitazar Magnesium) Tablet is a pioneering dual peroxisome proliferator-activated receptor (PPAR) agonist designed to manage diabetic dyslipidemia and hypertriglyceridemia in patients with Type 2 diabetes mellitus inadequately controlled by statins. Manufactured by Everest Pharmaceuticals Ltd., a WHO-GMP-certified leader in metabolic disorder therapies, and supplied globally by Onco Solution, Liposem 2 mg (Saroglitazar Magnesium) Tablet addresses both lipid […]
Ventoxen 100 MG (Venetoclax) Tablets
Introduction to Ventoxen 100 MG: A New Horizon in Oncology Care Ventoxen 100 mg, a groundbreaking development by Everest Pharmaceutical Ltd., marks a pivotal advancement in the field of oncology, particularly for patients with hematologic malignancies. This innovative medication, centered around the active ingredient Venetoclax, emerges as a beacon of hope in cancer treatment. Supplier […]
Gilternib 40 MG (Gilteritinib) Tablets
Introduction: Gilternib 40 mg, infused with Selpercatinib and developed by Everest Pharmaceutical Ltd., heralds a significant milestone in precision oncology. This novel medication delivers targeted therapy to patients with specific genetic mutations, offering renewed hope and substantially improved outcomes for those battling advanced cancer forms. Description and Usage: Gilternib 40 mg incorporates Selpercatinib, a selective […]
Ivosenib 250 MG (Ivosidenib) Tablets
Introduction to Ivosenib 250 MG: Targeting IDH1 Mutations in Cancer Ivosenib 250 belongs to a class of medications known as IDH1 inhibitors. Mutations in the isocitrate dehydrogenase 1 (IDH1) gene are prevalent in various cancers, including acute myeloid leukemia (AML) and gliomas. These mutations trigger the production of oncometabolite 2-hydroxyglutarate (2-HG), fostering tumorigenesis and disease […]
Moboxen 40 MG (Mobocertinib) Capsules
Introduction to Moboxen 40 mg Moboxen 40 mg, crafted by Everest Pharmaceutical Ltd., represents a groundbreaking advancement in the field of precision oncology. Infused with the active ingredient Mobocertinib, this medication is specifically designed to target genetic mutations, providing new hope and significantly improved treatment outcomes for patients battling specific types of cancer. Description and […]
Selinex 20 MG (Selinexor) Tablets
Introduction: Selinex 20 mg, featuring Selinexor as its key component and crafted by Everest Pharmaceutical Ltd., emerges as a pivotal development in oncology. This medication embodies a new phase in cancer therapy, offering targeted treatment for patients with specific cancer types, fostering hope, and significantly improving their treatment journey. Description and Usage: Selinex 20 mg […]
Tivoxen 1.34 MG (Tivozanib) Capsule
Introduction to Tivoxen 1.34 mg Tivoxen 1.34 mg, featuring Tivozanib as its active ingredient and developed by Everest Pharmaceutical Ltd., represents a transformative breakthrough in the treatment of oncology. This medication delivers targeted therapy for patients with specific cancer types, ushering in renewed hope and significantly improved treatment outcomes. Description and Usage of Tivoxen Tivoxen […]
Trifluxen 15 MG +6.14 MG (Trifluridine and Tipircil) Tablets
Introduction of Trifluxen 15 mg +6.14 mg Trifluxen, encompassing 15 mg of Trifluridine and 6.14 mg of Tipiracil and produced by Everest Pharmaceutical Ltd., introduces a significant breakthrough in the field of oncology therapeutics. It offers a beacon of hope for patients grappling with specific cancer types, heralding a new era of improved outcomes and […]
Ventoxen 10 MG (Venetoclax) Tablets
Introduction: In the realm of modern oncology, Ventoxen 10 mg, imbued with the active compound Venetoclax, emerges as a landmark achievement by Everest Pharmaceutical Ltd., heralding a new dawn in cancer treatment. This medicine is specifically engineered for patients contending with hematological malignancies, illuminating a path of hope and innovation. Onco Solution, by bridging global […]
Alkixen 250 mg (Crizotinib) Capsules
Introduction: Alkixen 250 mg, containing Crizotinib and manufactured by Everest Pharmaceuticals Ltd., stands at the forefront of cancer treatment innovation. This medication represents a paradigm shift in the management of certain types of cancer, offering new hope and improved outcomes for patients worldwide. Description and Usage: Alkixen 250 mg is formulated with Crizotinib, a potent […]